Fighting breast cancer with a new generation of diagnostic tests
BIOARRAY tests will provide a patient and their doctor with information they need to make informed and personalized decisions about breast cancer treatment.
May 20, 2013 ---- The Avon Foundation, Connecticut Innovations, and private angel investors award a total of $400,000 to BIOARRAY enabling development of lead diagnostic test. (Press release)
April 11, 2012 ---- BIOARRAY’s CEO part of a select group of political and business leaders who had lunch with Brazil’s President Dilma Rousseff yesterday. (Press release)
December 5, 2011 ---- BIOARRAY CEO is Brazil expert on trade mission with Govenor Patrick. (Boston Business Journal)
November 16, 2011 ---- BIOARRAY Founder & CEO Marcia Fournier invited to join MA Gov. Patrick on trade mission to Brazil.(Press release)
October 24, 2011 ---- BIOARRAY is Silver Winner of MassChallenge. (Press release)
June 3, 2011 ---- BIOARRAY publishes results for Chemotherapy Response Prediction Test in Journal of Clinical Oncology. (Abstract)
